Wuyi Focuses On Producing Prescription Drugs For China
This article was originally published in PharmAsia News
Executive Summary
China's Wuyi International Pharmaceutical has set a goal of producing a new drug a year as it increases the pharmaceutical portion of its drug business, currently 64 percent. The firm has been around for more than a century, but until its Fujian Sanai subsidiary was established in 2000 and a drug manufacturing license acquired the following year, Wuyi had been producing traditional Chinese medicines. Chairman Lin Ou Wen said the company intends to continue its focus on selling its prescription drugs only to hospitals and clinics, unlike other makers who focus more on over-the-counter products. Lin said prescription drugs are more stable. (Click here for more